Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2008 2
2009 5
2010 5
2011 3
2012 4
2013 2
2014 2
2015 1
2016 3
2017 3
2018 2
2019 1
2020 1
2023 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

30 results

Results by year

Filters applied: . Clear all
Page 1
The predictive value of stable precursor fragments of vasoactive peptides in patients with chronic heart failure: data from the GISSI-heart failure (GISSI-HF) trial.
Masson S, Latini R, Carbonieri E, Moretti L, Rossi MG, Ciricugno S, Milani V, Marchioli R, Struck J, Bergmann A, Maggioni AP, Tognoni G, Tavazzi L; GISSI-HF Investigators. Masson S, et al. Eur J Heart Fail. 2010 Apr;12(4):338-47. doi: 10.1093/eurjhf/hfp206. Epub 2010 Jan 22. Eur J Heart Fail. 2010. PMID: 20097683 Free article. Clinical Trial.
Cancer in chronic heart failure patients in the GISSI-HF trial.
Ameri P, Canepa M, Luigi Nicolosi G, Marchioli R, Latini R, Tavazzi L, Maggioni AP; GISSI-HF Investigators. Ameri P, et al. Eur J Clin Invest. 2020 Sep;50(9):e13273. doi: 10.1111/eci.13273. Epub 2020 May 31. Eur J Clin Invest. 2020. PMID: 32406516
Modes of death and prognostic outliers in chronic heart failure.
Canepa M, Ameri P, Lucci D, Nicolosi GL, Marchioli R, Porcu M, Tognoni G, Franzosi MG, Latini R, Maseri A, Tavazzi L, Maggioni AP; GISSI-HF Investigators. Canepa M, et al. Am Heart J. 2019 Feb;208:100-109. doi: 10.1016/j.ahj.2018.11.009. Epub 2018 Nov 24. Am Heart J. 2019. PMID: 30580128
Interaction of Galectin-3 Concentrations with the Treatment Effects of β-Blockers and RAS Blockade in Patients with Systolic Heart Failure: A Derivation-Validation Study from TIME-CHF and GISSI-HF.
Sanders-van Wijk S, Masson S, Milani V, Rickenbacher P, Gorini M, Tavazzi LT, Tobler D, Rickli H, Latini R, Brunner-La Roccaenen HP; TIME-CHF Investigators and the GISSI-HF Investigators. Sanders-van Wijk S, et al. Clin Chem. 2016 Apr;62(4):605-16. doi: 10.1373/clinchem.2015.246850. Epub 2016 Mar 2. Clin Chem. 2016. PMID: 26936932
Prognostic impact of elevated serum uric acid levels on long-term outcomes in patients with chronic heart failure: A post-hoc analysis of the GISSI-HF (Gruppo Italiano per lo Studio della Sopravvivenza nella Insufficienza Cardiaca-Heart Failure) trial.
Mantovani A, Targher G, Temporelli PL, Lucci D, Gonzini L, Nicolosi GL, Marchioli R, Tognoni G, Latini R, Cosmi F, Tavazzi L, Maggioni AP; GISSI-HF Investigators. Mantovani A, et al. Metabolism. 2018 Jun;83:205-215. doi: 10.1016/j.metabol.2018.02.007. Epub 2018 Mar 29. Metabolism. 2018. PMID: 29477817 Clinical Trial.
30 results